Related Experiment Videos
Current consensus on the management of primary sclerosing cholangitis
1Medical Department, Baerum Hospital, Vestre Viken Hospital Trust, Drammen, Norway.
Clinics and Research in Hepatology and Gastroenterology
|October 4, 2011
Summary
Primary sclerosing cholangitis (PSC) management lacks medical therapy. Guidelines suggest endoscopic therapy for strictures and liver transplantation for end-stage disease, with ongoing research needed for ursodeoxycholic acid (UDCA) efficacy.
Area of Science:
- Hepatology and Gastroenterology
- Autoimmune Liver Diseases
- Biliary System Disorders
Background:
- Primary sclerosing cholangitis (PSC) is a chronic liver disease with no established medical treatments.
- Recent guidelines from EASL and AASLD offer updated management strategies for PSC.
- The efficacy of ursodeoxycholic acid (UDCA) in PSC remains uncertain.
Purpose of the Study:
- To review and summarize current management guidelines for primary sclerosing cholangitis (PSC).
- To highlight evidence-based recommendations for PSC treatment and follow-up.
- To identify areas requiring further research in PSC management.
Main Methods:
- Review of recently published management guidelines for PSC by EASL and AASLD.
- Synthesis of recommendations regarding medical therapy, endoscopic interventions, and liver transplantation.
- Identification of current surveillance and follow-up protocols for PSC patients.
Main Results:
- No definitive medical therapy currently exists for PSC.
- Endoscopic therapy (biliary dilatation with or without stenting) is recommended for dominant strictures.
- Liver transplantation is a recommended option for end-stage PSC and for patients with dysplasia.
Conclusions:
- Current PSC management relies on symptomatic treatment, endoscopic interventions, and transplantation.
- Further prospective studies are needed to clarify the role of UDCA and optimize endoscopic therapies.
- Regular surveillance, including colonoscopies for IBD and ultrasounds for gallbladder lesions, is advised.
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:30Acute Pancreatitis II: Clinical Manifestations and Management
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
01:20Cholecystitis
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...